The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis
about
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.Fc gamma receptor CD64 modulates the inhibitory activity of infliximabEffects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen Registry.Multivariate meta-analysis of mixed outcomes: a Bayesian approach.A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathwaysPatterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab.Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitorsSuppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model.Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series.Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor BlockadeCertolizumab in the long-term treatment of rheumatoid arthritis.Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis.Biologics-based therapy for the treatment of rheumatoid arthritis.When is switching warranted among biologic therapies in rheumatoid arthritis?Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy.Comparative effectiveness of anti-tumor necrosis factor drugs on health-related quality of life among patients with inflammatory arthritis.Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature.Severe infliximab-induced psoriasis treated with adalimumab switching.Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry.Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice
P2860
Q27335069-1F685CE9-C79B-4766-97FF-90C4319E7CEFQ28482601-46334298-E404-483D-9DB5-5F3D7966B91EQ30841797-2F703FA8-F6D8-4D3C-8ADC-0F1467009D73Q33587615-8C5A3093-911F-4D30-9EB5-3B813A0DBD84Q33689506-EC1EB92A-6A80-4803-847E-800CBEEA8AD2Q34022346-9A958B22-1468-4DAD-BDA1-52AE541DC9C6Q35610243-3491A76A-2AA0-4B64-A868-49A51F36C296Q35620336-4DC9F114-6948-4088-809A-37E26DEED39BQ35655587-A1E22E49-6DC1-4B74-B093-392C2A7F30B8Q35695052-46F4D692-D2A5-4D3D-B844-FBF4DE63E952Q36536688-54BFB04B-154D-4311-8060-42FB69622A54Q37358254-92E81CBC-34C4-4369-B2F6-39924E7F9F08Q37572857-4B721678-0492-45ED-8ADB-70B2AAB223CAQ37868377-B604A3A1-31D0-423F-9D0B-5C3626B0E616Q37968143-7EB81864-9160-48B4-A1B0-E646511B4F96Q38027571-08B30C53-C335-437E-8B4A-D376D57DCB53Q38055244-9CD821D6-A378-43FE-8353-E856D35D8893Q38424589-DC8FC580-D9A8-4C72-B996-25372048FFC5Q38804610-68AF63A4-6C16-4C7E-AE2C-BF5A145AAA7DQ38978414-0DACCFF0-4D07-423D-946D-B1CF1F33EAF9Q44576832-EF115A01-2D4E-4018-AE4E-5D962840AB7CQ46894147-251A32E3-338E-43BE-A74E-18C45BF015F2Q48494568-0A9F510F-DD7B-4A07-A106-B534948881D2Q57483996-37B5F87E-7344-4070-8D31-9DE08352CA53
P2860
The effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@ast
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@en
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@nl
type
label
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@ast
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@en
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@nl
prefLabel
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@ast
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@en
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
The effectiveness of anti-TNF- ...... matic review and meta-analysis
@en
P2093
Alex J Sutton
Allan J Wailoo
David Scott
Suzanne Lloyd
P275
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ169
P5008
P577
2010-06-21T00:00:00Z
2010-12-01T00:00:00Z